Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas.

Todoric J, Antonucci L, Di Caro G, Li N, Wu X, Lytle NK, Dhar D, Banerjee S, Fagman JB, Browne CD, Umemura A, Valasek MA, Kessler H, Tarin D, Goggins M, Reya T, Diaz-Meco M, Moscat J, Karin M.

Cancer Cell. 2017 Dec 11;32(6):824-839.e8. doi: 10.1016/j.ccell.2017.10.011. Epub 2017 Nov 16.

2.

Update on clinical and mechanistic aspects of paraneoplastic syndromes.

Tarin D.

Cancer Metastasis Rev. 2013 Dec;32(3-4):707-21. doi: 10.1007/s10555-013-9446-4. Review.

PMID:
24052434
3.

Role of the host stroma in cancer and its therapeutic significance.

Tarin D.

Cancer Metastasis Rev. 2013 Dec;32(3-4):553-66. doi: 10.1007/s10555-013-9438-4. Review.

PMID:
23625010
4.

Loss of acinar cell IKKα triggers spontaneous pancreatitis in mice.

Li N, Wu X, Holzer RG, Lee JH, Todoric J, Park EJ, Ogata H, Gukovskaya AS, Gukovsky I, Pizzo DP, VandenBerg S, Tarin D, Atay C, Arkan MC, Deerinck TJ, Moscat J, Diaz-Meco M, Dawson D, Erkan M, Kleeff J, Karin M.

J Clin Invest. 2013 May;123(5):2231-43. doi: 10.1172/JCI64498. Epub 2013 Apr 8.

5.

Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression.

Ward KK, Tancioni I, Lawson C, Miller NL, Jean C, Chen XL, Uryu S, Kim J, Tarin D, Stupack DG, Plaxe SC, Schlaepfer DD.

Clin Exp Metastasis. 2013 Jun;30(5):579-94. doi: 10.1007/s10585-012-9562-5. Epub 2012 Dec 30.

6.

Tailored immunoconjugate therapy depending on a quantity of tumor stroma.

Yasunaga M, Manabe S, Tarin D, Matsumura Y.

Cancer Sci. 2013 Feb;104(2):231-7. doi: 10.1111/cas.12062. Epub 2012 Dec 16.

7.

Clinical and biological implications of the tumor microenvironment.

Tarin D.

Cancer Microenviron. 2012 Aug;5(2):95-112. doi: 10.1007/s12307-012-0099-6. Erratum in: Cancer Microenviron. 2012 Aug;5(2):113.

8.

Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance.

Tarin D.

Cancer Metastasis Rev. 2012 Jun;31(1-2):21-39. doi: 10.1007/s10555-011-9326-8. Review.

PMID:
22138779
9.

Cancer-stroma targeting therapy by cytotoxic immunoconjugate bound to the collagen 4 network in the tumor tissue.

Yasunaga M, Manabe S, Tarin D, Matsumura Y.

Bioconjug Chem. 2011 Sep 21;22(9):1776-83. doi: 10.1021/bc200158j. Epub 2011 Aug 4.

PMID:
21749132
10.

Oncogenic Ras/Src cooperativity in pancreatic neoplasia.

Shields DJ, Murphy EA, Desgrosellier JS, Mielgo A, Lau SK, Barnes LA, Lesperance J, Huang M, Schmedt C, Tarin D, Lowy AM, Cheresh DA.

Oncogene. 2011 May 5;30(18):2123-34. doi: 10.1038/onc.2010.589. Epub 2011 Jan 17.

11.

Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance.

Tarin D.

Semin Cancer Biol. 2011 Apr;21(2):72-82. doi: 10.1016/j.semcancer.2010.12.006. Epub 2010 Dec 13. Review.

PMID:
21147229
12.

RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia.

Shields DJ, Niessen S, Murphy EA, Mielgo A, Desgrosellier JS, Lau SK, Barnes LA, Lesperance J, Bouvet M, Tarin D, Cravatt BF, Cheresh DA.

Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2189-94. doi: 10.1073/pnas.0911646107. Epub 2009 Dec 28.

13.

An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression.

Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prévost N, Tarin D, Shattil SJ, Cheresh DA.

Nat Med. 2009 Oct;15(10):1163-9. doi: 10.1038/nm.2009. Epub 2009 Sep 6.

14.

Expression of melanocyte-related genes in human breast cancer and its implications.

Montel V, Suzuki M, Galloy C, Mose ES, Tarin D.

Differentiation. 2009 Dec;78(5):283-91. doi: 10.1016/j.diff.2009.07.007. Epub 2009 Aug 21.

PMID:
19699574
15.

Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry.

Leth-Larsen R, Lund R, Hansen HV, Laenkholm AV, Tarin D, Jensen ON, Ditzel HJ.

Mol Cell Proteomics. 2009 Jun;8(6):1436-49. doi: 10.1074/mcp.M800061-MCP200. Epub 2009 Mar 24.

16.

Comparisons of metastases in different organs: biological and clinical implications.

Tarin D.

Clin Cancer Res. 2008 Apr 1;14(7):1923-5. doi: 10.1158/1078-0432.CCR-07-5259. Review. No abstract available.

17.

Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications.

Suzuki M, Tarin D.

Mol Oncol. 2007 Sep;1(2):172-80. doi: 10.1016/j.molonc.2007.03.005. Epub 2007 Apr 7. Erratum in: Mol Oncol. 2008 Apr;1(4):440.

18.

Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.

Suzuki M, Mose E, Galloy C, Tarin D.

Am J Pathol. 2007 Aug;171(2):682-92. Epub 2007 Jul 9.

19.

New insights into the pathogenesis of breast cancer metastasis.

Tarin D.

Breast Dis. 2006-2007;26:13-25. Review.

PMID:
17473363
20.

Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency.

Suzuki M, Mose ES, Montel V, Tarin D.

Am J Pathol. 2006 Aug;169(2):673-81.

21.

Effect of the reduction of superoxide dismutase 1 and 2 or treatment with alpha-tocopherol on tumorigenesis in Atm-deficient mice.

Erker L, Schubert R, Elchuri S, Huang TT, Tarin D, Mueller K, Zielen S, Epstein CJ, Wynshaw-Boris A.

Free Radic Biol Med. 2006 Aug 15;41(4):590-600. Epub 2006 May 10.

PMID:
16863992
22.
23.

The fallacy of epithelial mesenchymal transition in neoplasia.

Tarin D, Thompson EW, Newgreen DF.

Cancer Res. 2005 Jul 15;65(14):5996-6000; discussion 6000-1. Review.

24.

Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

Thompson EW, Newgreen DF, Tarin D.

Cancer Res. 2005 Jul 15;65(14):5991-5; discussion 5995. Review. No abstract available.

25.

Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model.

Montel V, Huang TY, Mose E, Pestonjamasp K, Tarin D.

Am J Pathol. 2005 May;166(5):1565-79.

26.
27.

Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression.

Montel V, Kleeman J, Agarwal D, Spinella D, Kawai K, Tarin D.

Cancer Res. 2004 Mar 1;64(5):1687-94.

28.

In silico dissection of cell-type-associated patterns of gene expression in prostate cancer.

Stuart RO, Wachsman W, Berry CC, Wang-Rodriguez J, Wasserman L, Klacansky I, Masys D, Arden K, Goodison S, McClelland M, Wang Y, Sawyers A, Kalcheva I, Tarin D, Mercola D.

Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):615-20.

29.

Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein.

Goodison S, Kawai K, Hihara J, Jiang P, Yang M, Urquidi V, Hoffman RM, Tarin D.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3808-14.

30.

Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.

Hooper JD, Zijlstra A, Aimes RT, Liang H, Claassen GF, Tarin D, Testa JE, Quigley JP.

Oncogene. 2003 Mar 27;22(12):1783-94.

PMID:
12660814
31.
33.

Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines.

Euer N, Schwirzke M, Evtimova V, Burtscher H, Jarsch M, Tarin D, Weidle UH.

Anticancer Res. 2002 Mar-Apr;22(2A):733-40.

PMID:
12014644
34.

Comprehensive karyotyping of the HT-29 colon adenocarcinoma cell line.

Kawai K, Viars C, Arden K, Tarin D, Urquidi V, Goodison S.

Genes Chromosomes Cancer. 2002 May;34(1):1-8.

PMID:
11921276
35.
36.

Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines.

Schwirzke M, Evtimova V, Burtscher H, Jarsch M, Tarin D, Weidle UH.

Anticancer Res. 2001 May-Jun;21(3B):1771-6.

PMID:
11497258
37.

PTEN expression is maintained in sporadic colorectal tumours.

Taniyama K, Goodison S, Ito R, Bookstein R, Miyoshi N, Tahara E, Tarin D, Urquidi V.

J Pathol. 2001 Jul;194(3):341-8.

PMID:
11439367
38.

Telomerase activity in soft-tissue and bone sarcomas.

Aogi K, Woodman A, Urquidi V, Mangham DC, Tarin D, Goodison S.

Clin Cancer Res. 2000 Dec;6(12):4776-81.

39.
40.

Role of telomerase in cell senescence and oncogenesis.

Urquidi V, Tarin D, Goodison S.

Annu Rev Med. 2000;51:65-79. Review.

PMID:
10774453
41.

CD44 cell adhesion molecules.

Goodison S, Urquidi V, Tarin D.

Mol Pathol. 1999 Aug;52(4):189-96. Review.

42.

Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid.

Aogi K, Kitahara K, Urquidi V, Tarin D, Goodison S.

Clin Cancer Res. 1999 Oct;5(10):2790-7.

43.

CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma.

Gorham H, Woodman A, Goodison S, Marsh J, Charnock M, Manek S, Sugino T, Tarin D.

Mol Diagn. 1999 Mar;4(1):45-56.

PMID:
10229774
44.

Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions.

Sugino T, Yoshida K, Zhao S, Goodison S, Tarin D.

J Pathol. 1998 Sep;186(1):17-23.

PMID:
9875135
45.

Telomerase in cancer: clinical applications.

Urquidi V, Tarin D, Goodison S.

Ann Med. 1998 Oct;30(5):419-30. Review.

PMID:
9814828
46.

Multiple intron retention occurs in tumor cell CD44 mRNA processing.

Goodison S, Yoshida K, Churchman M, Tarin D.

Am J Pathol. 1998 Oct;153(4):1221-8.

47.

Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates.

Aogi K, Kitahara K, Buley I, Backdahl M, Tahara H, Sugino T, Tarin D, Goodison S.

Clin Cancer Res. 1998 Aug;4(8):1965-70.

48.

Differential gene expression in mammary carcinoma cell lines: identification of DRIM, a new gene down-regulated in metastasis.

Schwirzke M, Gnirke A, Bork P, Tarin D, Weidle UH.

Anticancer Res. 1998 May-Jun;18(3A):1409-21.

PMID:
9673349
49.

Clinical implications of anomalous CD44 gene expression in neoplasia.

Goodison S, Tarin D.

Front Biosci. 1998 Jul 1;3:e89-109. Review.

PMID:
9634541
50.

CD44 variant isoform expression and breast cancer prognosis.

Tokue Y, Matsumura Y, Katsumata N, Watanabe T, Tarin D, Kakizoe T.

Jpn J Cancer Res. 1998 Mar;89(3):283-90.

Supplemental Content

Support Center